Non-surgical treatment of skin cancer

Australasian Journal of Dermatology

Volumn 46, Issue SUPPL., 2005, Pages

  Morton, Colin A ^a  

^a Ward 17 Falkirk Community Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIETHYL 3 HYDROXY 4 PYRIDONE; AMINOLEVULINIC ACID METHYL ESTER; DEOXYRIBONUCLEASE (PYRIMIDINE DIMER); DICLOFENAC; FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONFERENCE PAPER; CRYOTHERAPY; CUTANEOUS T CELL LYMPHOMA; DRUG EFFICACY; DRY SKIN; EDEMA; EROSION; ERYTHEMA; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; MOUSE; NONHUMAN; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRURITUS; RASH; SCAR; SIDE EFFECT; SKIN CANCER; SKIN IRRITATION; SKIN ULCER;

EID: 14244269960     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2004.00112.x     Document Type: Conference Paper

References (20)

1. Harrison CJ, Jenski L, Voychehovski T, Bernstein DI. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection. Antiviral Res. 1988; 10: 209-23.
2. Sidky YA, Borden EC, Weeks CE, Hatcher JF, Bryan GT. Inhibition of murine tumour growth by an interferon-inducing imidazoquinolinamine. Cancer Res. 1992; 52: 3528-33.
3. Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch. Dermatol. 2002; 138: 1498-502.
4. Jorrizo J, Lebwohl M, Salache S, Stockfleth E. Different dosing regimens of imiquimod 5% cream can be used to safely and effectively treat actinic keratosis. J. Am. Acad. Dermatol. 2004; 50: 126.
5. Gollnick H, Guillen Barona C, Frank R, Ruzicka T. Efficacy by clinical evaluation of imiquimod 5% cream in the treatment of superficial basal cell carcinomas: initial results from an ongoing, long-term follow-up study in Europe. J. Am. Acad. Dermatol. 2004; 50: 124.
6. Geisse JR, Rich P, Pandya A, Gross K, Andres K, Ginkel A, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J. Am. Acad. Dermatol. 2002; 47: 390-8.
7. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J. Am. Acad. Dermatol. 2004; 50: 722-33.
8. Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, Andres K., Amies M, Owens M. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch. Dermatol. 2002; 138: 1165-71.
9. MacKenzie-Wood A, Kossard S, de Launey J, Wilkinson B, Owens ML. Imiquimod 5% cream in the treatment of Bowen's disease. J. Am. Acad. Dermatol 2001; 44: 462-70.
10. Rivers JK, Arlette J, Shear N, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br. J. Dermatol. 2002; 146: 94-100.
11. Morton CA, Horn M, Leman J, Tack B, Bedane C, Tijioe M, Ibbotson S, Khemis D, Wolf P. A placebo-controlled multicentre study comparing photodynamic therapy using methyl aminolaevulinate with cryotherapy and 5-fluorouracil in Bowen's disease. Br. J. Dermatol. 2004; 151 (Suppl 68): 2.
12. Basset-Sequin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J. Eur. Acad. Dermatol. Venerol. 2001; 15 (Suppl 2): 226.
13. Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V, Wong GA, Grob JJ, Varma S, Wolf P. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch. Dermatol. 2004; 140: 17-23.
14. th World Congress of Cancers of the Skin, Seville, May 7-10, 2003.
15. Slender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem. Photobiol. 1997; 66: 493-6.
16. Moan J, Ma LW, Juzeniene A, Apricena F, Peng Q. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int. J. Cancer 2003; 103: 132-5.
17. Moan J, Juzeniene A, Juzenas P, Wei Ma L, Iani V. A pigment-generating and anti-photocarcinogenic sunscreen based on ALA derivatives. J. Dermatolog. Treat. 2004; 15: 260.
18. Curnow A. Photodynamic therapy with 5-aminolaevulinic acid - Techniques for enhancemenl (PhD Thesis). London, University of London, 1999.
19. Morton CA, Campbell S, Gould D, Alhia R, Saller L, Curnow A. Topical photodynamic therapy with iron chelator CP94 for nodular basal cell carcinoma. J. Dermatolog. Treat. 2004; 15: 268.
20. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Sludy Group. Lancet 2001; 357: 926-9.